Study to Assess the EffectiVeness of exIsting Anti-vascular Endothelial groWth Factor (Anti-VEGF) Treatment Regimens in Patients With Wet Age-related Macular Degeneration
CompletedOBSERVATIONAL
Enrollment
137
Participants
Timeline
Start Date
August 31, 2012
Primary Completion Date
April 30, 2013
Study Completion Date
April 30, 2013
Conditions
Macular Degeneration
Interventions
DRUG
Ranibizumab
Patients with wet AMD treated with ranibizumab as prescribed by physician
NCT01933152 - Study to Assess the EffectiVeness of exIsting Anti-vascular Endothelial groWth Factor (Anti-VEGF) Treatment Regimens in Patients With Wet Age-related Macular Degeneration | Biotech Hunter | Biotech Hunter